EN
HI
Transgene Biotek Chart
Transgene Biotek Share Key Metrics
Volume
13992.00
Market Cap
23.03 CR
LTQ@LTP
2@3.02
ATP
3.09
Var Margin
100 %
Circuit Range
2.44-3.64
Delivery %
62.56 %
Value
43235.28
ASM/GSM
No
Market Lot
1
Summary
Transgene Biotek share price is ₹3.02 as of 10 Jun, 2026. The stock Transgene Biotek intraday movement has stayed between ₹2.85 and ₹3.25, while on a 52-week basis,Transgene Biotek price 52 week high is ₹5.26 & its 52 week low is ₹1.83.
In terms of trading activity, Transgene Biotek has recorded a volume of 13992 shares, The Transgene Biotek has a market cap of ₹75770000 CR. The stock’s Average Traded Price (ATP) stands at ₹3.09, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2 @ ₹3.02.
Transgene Biotek operates within a circuit range of ₹2.44 – ₹3.64, with a Value of ₹43235.28. The Delivery Percentage for the day is 62.56%. Additionally, Transgene Biotek currently falls under the No framework, and trades with a market lot size of 1.
Transgene Biotek Fundamentals
P/E Ratio
0
P/B Ratio
2.75
Div. Yield
0
Sector P/E
24.53
Sector P/B
2.83
Sec. Div. Yield
1.37
Transgene Biotek Resistance and Support
Pivot 3.06
Resistance
First Resistance
3.16
Second Resistance
3.29
Third Resistance
3.39
Support
First Support
2.93
Second Support
2.83
Third Support
2.7
Transgene Biotek Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-29 | Audited Results |
| 2026-02-13 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-07 | Audited Results |
| 2025-01-24 | Quarterly Results |
Transgene Biotek News
Transgene Biotek Ltd - 526139 - Board Meeting Outcome for Outcome Of Board Meeting And Submission Of Audited Financial Results For The Fourth Quarter And Financial Year Ended March 31, 2026
Transgene Biotek's board approved audited financial results for FY26, reporting a net loss of ₹1.65 crores. The company also announced a net loss of ₹0.46 crores for Q4 FY26, with an unmodified auditor's opinion.
May 29 2026 11:35:28
Transgene Biotek Ltd - 526139 - Board Meeting Intimation for Intimation Of The Board Meeting Of The Company - This Is To Inform You That A Meeting Of Board Of Directors Of The Company Will Be Held On Friday 29Th May 2026.
Transgene Biotek's Board of Directors is scheduled to meet on May 29, 2026. The primary agenda is to consider and approve the audited financial results for the fourth quarter and the financial year ended March 31, 2026 (both standalone and consolidated).
May 15 2026 09:25:22
Transgene Biotek Management
| Name | Position |
|---|---|
| K Koteswara Rao | Chairman & Managing Director |
| Sujana Kadiam | Non Executive Independent Director |
Transgene Biotek Similar Stocks
Sarthak Industries Ltd.
26.00
0.07 (0.27%)
Shree Marutinandan Tubes Ltd.
67.90
-0.50 (0.73%)
Shree Metalloys Ltd.
40.20
-0.59 (1.45%)
Naturo Agrotech India Ltd.
2.50
0.00 (0.00%)
Bothra Metals & Alloys Ltd.
7.30
0.00 (0.00%)
Neeraj Paper Marketing Ltd.
21.00
0.00 (0.00%)
Yash Innoventures Ltd.
46.00
-1.13 (2.40%)
LWS Knitwear Ltd.
15.55
-0.34 (2.14%)
Transgene Biotek FAQs
The Buying Price of Transgene Biotek share is 3.02 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Transgene Biotek stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Transgene Biotek, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Transgene Biotek shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Transgene Biotek shares is 2.75. Useful to assess the stock's value relative to its book value.
To assess Transgene Biotek’s valuation compare Sector P/E, P/B which are 24.53 & 2.83 with sector averages, along with growth rates and financial metrics.
The Market Cap of Transgene Biotek is 23.03 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Transgene Biotek share price is 5.26 & 1.83. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Transgene Biotek belongs to the Miscellaneous sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
